Skip to content

Sodium acetate

BLOOD AND BLOOD FORMING ORGANS

Also known as: acetic acid, sodium salt, anhydrous sodium acetate, sodium acetate anhydrous

FDA approvedATC B05XA08

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Sodium acetate is a drug catalogued in DrugCentral. It was first approved by the FDA in 1983. DrugCentral lists 2 molecular targets, including CA1 and NCE103.

  • Molecular targets: CA1 and NCE103 (2 listed in DrugCentral).
  • ATC code: B05XA08 (Electrolyte solutions).
  • Molecular formula: C2H3NaO2; molecular weight 82.03 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Contraindications (23)

  • Acute nephropathy
  • Anuria
  • Azotemia
  • Classical phenylketonuria
  • Complete atrioventricular block
  • Congenital myotonia, autosomal dominant form
  • End stage renal disease
  • Familial hyperkalemic periodic paralysis
  • Heart disease
  • Humoral hypercalcemia of malignancy
  • Hypercalcemia
  • Hypercalciuria
  • Hyperchloremia
  • Hyperkalemia
  • Hyporeninemic hypoaldosteronism
  • Kidney disease
  • Kidney stone
  • Oliguria
  • Poisoning by digitalis glycoside
  • Sarcoidosis
  • Severe dehydration
  • Third degree burn injury
  • Ventricular fibrillation

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
Carbonic anhydrase 1CA1unknownKi 4.97
Carbonic anhydraseNCE103unknownKi 4.44

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1983-05-04FDA—HOSPIRA

ATC classification

ATC codeTherapeutic hierarchy
B05XA08BLOOD AND BLOOD FORMING ORGANS › BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS › I.V. SOLUTION ADDITIVES › Electrolyte solutions

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Toxic anterior segment syndrome1275.3
Endophthalmitis386.6
Post procedural complication173.3
Anterior chamber cell169.4
Cataract operation complication140.7
Eye inflammation117.1
Anterior chamber disorder83.6
Corneal oedema77.3
Keratitis74.1
Anterior chamber inflammation63.2
Iridocyclitis52.9
Intraocular pressure increased51.5

Chemical structure

Molecular formulaC2H3NaO2
Molecular weight82.03 g/mol
CAS number127-09-3
InChIKey—
PubChem CID517045

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Sodium acetate work?

Its molecular targets in DrugCentral include CA1 and NCE103.

When was Sodium acetate first approved?

Sodium acetate was first approved by the FDA in 1983.

What is the chemical formula of Sodium acetate?

Sodium acetate has the molecular formula C2H3NaO2 and a molecular weight of 82.03 g/mol.

Browse: all drugs starting with S · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1983-05-04
AgencyFDA
Targets2
Indications0
FormulaC2H3NaO2
DrugCentral ID4203
Interactive profile